Search Icon
Notification Icon
Ham Icon
Quick Reads icon
Quick Reads
Events & Videos icon
Events & Videos
Explore icon
Explore
Product Index icon
Product Index
eCME icon
eCME

Sildenafil in PAH

calendar
1 Mar, 12
image NP
Slide 1/20
Expand Icon
This slide deck gives an overview of the mechanism of action, the key clinical trials (SUPER 1 & 2) along with the dosage and indications of sildenafil recommended for pulmonary arterial hypertension.
Related Topics
PH
arrow
PAH
arrow
SUPER Study
arrow

More From Area Of Interest
You may also like
Our Research
Efficacy & Safety of Torsemide & Spironolactone FDC in HF Patients: Insights from RESTORE HF Study
13 May, 26
CiplaMedLogo
13 May, 26
Our Research
Telmisartan & Amlodipine FDC for BP Control in Indian Patients with Hypertension: TACT‑India Study
17 Apr, 26
CiplaMedLogo
17 Apr, 26
Our Research
Physician Perspectives on Breath‑Actuated Inhalers: APPROACH Survey Interim Data
23 Feb, 26
CiplaMedLogo
23 Feb, 26
Our Research
An East region Subgroup Analysis from an Indian Cross-Sectional Study to Evaluate In-Clinic AR Burde...
11 Feb, 26
CiplaMedLogo
11 Feb, 26
Our Research
Role of Acebrophylline and its Combinations in the Management of Obstructive Airway Disease (ROAAD)
11 Feb, 26
CiplaMedLogo
11 Feb, 26
Our Research
In-Clinic AR Burden in Western India: Subgroup Analysis from a Multicenter Cross-Sectional Study Usi...
11 Feb, 26
CiplaMedLogo
11 Feb, 26
Latest Items